Estimates Revisions Danaher Corporation
Stocks
DHR
US2358511028
Advanced Medical Equipment & Technology
|
Market Closed -
NYSE
16:02:14 2026-09-01 EDT
|
5-day change | 1st Jan Change | ||
| 206.93 USD | -3.10% |
|
-4.19% | -9.61% |
| 09-01 | HSBC Adjusts Price Target on Danaher to $250 From $230, Maintains Buy Rating | MT |
| 08-24 | Cytek Biosciences Shares Drop After Jury Says It Owes $56 Million in Damages | DJ |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- DHR Stock
- Consensus Danaher Corporation
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
